The Practitioner (U.K.)
1964-10-01
CURRENT THERAPEUTICS. CCII. ACETOHEXAMIDE.
D A MONTGOMERY
Index: Practitioner 193 , 555-60, (1964)
Full Text: HTML
Abstract
Related Articles:
Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair.
2014-11-01
[Cancer Res. 74(21) , 6205-15, (2014)]
Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.
2014-12-05
[J. Chromatogr. A. 1371 , 82-9, (2014)]
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
2013-02-19
[Br. J. Cancer 108(3) , 570-8, (2013)]
Catalytic properties of carbonyl reductase from rabbit liver for analogs of acetohexamide and 4-acetylpyridine.
1994-08-01
[Biochem. Mol. Biol. Int. 33(5) , 893-9, (1994)]
Cadmium exposure decreases androgen-dependent metabolism of acetohexamide in liver microsomes of male rats through its testicular toxicity.
2002-02-01
[Arch. Toxicol. 76(1) , 8-12, (2002)]